In Memoriam
Douglas B. Cines, M.D.
Department: Pathology and Laboratory Medicine
Contact information
Dept. Pathology and Laboratory Medicine
513 A Stellar Chance
422 Curie Blvd.
University of Pennsylvania
Philadelphia, PA 19104
513 A Stellar Chance
422 Curie Blvd.
University of Pennsylvania
Philadelphia, PA 19104
Office: 215-662-3966
Fax: 215-573-2012
Fax: 215-573-2012
Publications
Education
A.B. (History, PreMed)
New York University, 1968.
M.D. (Medicine)
New York University School of Medicine, 1972.
Permanent linkA.B. (History, PreMed)
New York University, 1968.
M.D. (Medicine)
New York University School of Medicine, 1972.
Description of Research Expertise
Thormbosis, fibrinolysis, vascular biology, immunohematologyDescription of Clinical Expertise
Coagulation. Immune hematological disordersSelected Publications
Myoung S, Francis SJ, Chen J, Lee G, Rauova L, Poncz M, Cines DB, Kuchibhatla M, Khandelwal S, Arepally GM. : Complement Activation as a biomarker for platelet activating HIT antibodies. ASH 2024. ASH 2024.Sarkar A, Yadav SK, Field CO, Gollomp K, McCrae KM, Ortel T, Gruel Y, Rollen J, Arepally GM, Rauova L, Cines DB, Poncz M. : Anti-phospholipid syndrome (APS) antibody (Ab)-induced thrombosis can be blocked by platelet factor 4 (PF4)-directed Abs: A novel therapeutic for APS? ASH 2024.
Field CO, Sarkar A, Bdeir Kh, McRae KR, Ortel TL, Kowalska MA, Rauova L, Cines DB, Gollomp K, Poncz M. : Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder. ASH 2024.
Rauova L, Oberg J, Gilbert S, Cines DB, Poncz M. : A murine model of vaccine-induced immune thrombotic thrombocytopenia (VITT) leads to anti-NAP2 and anti-PF4 antibodies and may involve TLR9 activation. ISTH 2024.
Ngo ATP, Skidmore A, Yarovoi I, Sarkar A, Levine ND, Bochenek V, Zhao G, Rauova L, Kowalska MA, Eckart K, Mangalmurti NS, Rux A, Cines DB, Poncz M, Gollomp K.: Platelet factor 4 limits neutrophil extracellular trap- and cell-free DNA-induced thrombogenicity and endothelial injury. JCI-Insight. 8(22), November 2023.
Bussel JM, Hou M, Cines DB.: Management of primary ITP in pregnancy. New Eng J Med. 389(6): 540, August 2023.
Sarkar A, Khandelwal S, Koma G, Kim H, Gruel Y, Rollin J, Passam FH, Wool GD, Arepally GM, Cines DB, Rauova L, Poncz M.: Prevention of thrombocytopenia and thrombosis in HIT using deglycosylated KKO: a novel therapeutic? Blood Adv May 2023.
Cines DB, Greinacher A.: Vaccine-induced immune thrombotic thrombocytopenia. Blood 141: 1659-1665, Apr 2023.
Rauova L, Oberg J, Levine N, Bdeir Kh, Arepally GM, Cines DB, Gilbert S, Cohen T, Poncz M. : A novel adenovirus (AdV)-vaccinated murine model simulates the prothrombotic vaccine-induced immune thrombotic thrombocytopenia (VITT) clinical disorder. Am Soc Hematol 2023.
Cines DB. : Pathogenesis of refractory ITP: Overview. Br. J Haematol 2023.